Laparoscopic Revision From Biliopancreatic Diversion to Gastric Bypass
BPD-to-RYGB
Another Revisional Strategy to Address Severe Late Complications After Previous Biliopancreatic Diversion for Obesity: Major Revision From Standard Biliopancreatic Diversion to Proximal Roux-en-Y Gastric Bypass
2 other identifiers
observational
10
1 country
1
Brief Summary
The aim of this study is to describe the clinical presentation, indications, and operative treatment as well as assess the morbidity, mortality, and overall performance of revisional GBP after either failed and/or complicated Biliopancreatic Diversion "BPD" for weight loss. With such information, we hope to determine what features might assist us in advancing our knowledge about mechanisms of failure after primary bariatric surgery, mechanism of action of revisional GBP, and performance of revisional GBP through traditional outcome measurements as well as identifying predictors of good or poor outcome after revisional GBP in this specific subpopulation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Mar 2009
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2009
CompletedFirst Submitted
Initial submission to the registry
December 26, 2009
CompletedFirst Posted
Study publicly available on registry
December 31, 2009
CompletedJanuary 1, 2010
December 1, 2009
5 months
December 26, 2009
December 31, 2009
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Morbidity and mortality
at discharge, 1 week, 3 weeks, 8 weeks, 3 months, 6 months, 1 year and annually thereafter for up to 8 years
Weight loss expressed as Body Mass Index and Percentage of excess weight loss
at 6 months, 1 year and annually thereafter for up to 8 years
Secondary Outcomes (4)
Trend in comorbidities
at 6 months, 1 year, and annually thereafter for up to 8 years
Symptom resolution
at 6 months, 1 year, and annually thereafter for up to 8 years
Length of operative time which is defined as the time duration of operation measured in minutes from the first skin incision to the final closure of the skin incision
It is measured in minutes from the first skin incision to the final closure of the skin incision at the time of revisional surgery under study. It is a transoperative measure of outcome of the surgery under study
Length of Hospital Stay which is a measured of surgical recovery quantified and reported in days. It is a hospital pre-discharge traditional measure of outcome
It is measured in days from the admission date to the discharge date for the hospitalization pertaining to revisional surgery under study
Study Arms (1)
complicated and/or failed BPD
Eligibility Criteria
Patients referred with severe, persistent and/or recurrent metabolic/nutritional complications after open biliopancreatic diversion for clinically severe obesity underwent either laparoscopic or open conversion to Roux-en-Y gastric bypass. Intractability after interdisciplinary optimized medical therapy for metabolic and/or nutritional complications warranted surgical management.
You may qualify if:
- Patients status post biliopancreatic diversion with any combination of the following severe late complications:
- Metabolic and/or nutritional BPD-related complications.
- Excessive weight loss
- Poor weight loss, either Inadequate initial weight loss or Weight recidivism
- Intolerable intestinal malabsorptive symptoms without severe malnutrition
- Undergoing either open or laparoscopic conversion to Roux-en-Y gastric bypass (RYGB) surgery.
You may not qualify if:
- Any other type of revision or conversion surgery.
- Adequate response to medical management of metabolic and nutritional complications after previous BPD
- missing records and/or unreachable patients with scant information for analysis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UCSF Fresno Center for Medical Education and Research
Fresno, California, 93701, United States
Related Publications (71)
Higa KD, Boone KB, Ho T, Davies OG. Laparoscopic Roux-en-Y gastric bypass for morbid obesity: technique and preliminary results of our first 400 patients. Arch Surg. 2000 Sep;135(9):1029-33; discussion 1033-4. doi: 10.1001/archsurg.135.9.1029.
PMID: 10982506BACKGROUNDHedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, Flegal KM. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA. 2004 Jun 16;291(23):2847-50. doi: 10.1001/jama.291.23.2847.
PMID: 15199035BACKGROUNDMcTigue KM, Harris R, Hemphill B, Lux L, Sutton S, Bunton AJ, Lohr KN. Screening and interventions for obesity in adults: summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2003 Dec 2;139(11):933-49. doi: 10.7326/0003-4819-139-11-200312020-00013.
PMID: 14644897BACKGROUNDBuchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, Schoelles K. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004 Oct 13;292(14):1724-37. doi: 10.1001/jama.292.14.1724.
PMID: 15479938BACKGROUNDChristou NV, Sampalis JS, Liberman M, Look D, Auger S, McLean AP, MacLean LD. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg. 2004 Sep;240(3):416-23; discussion 423-4. doi: 10.1097/01.sla.0000137343.63376.19.
PMID: 15319713BACKGROUNDAdams TD, Gress RE, Smith SC, Halverson RC, Simper SC, Rosamond WD, Lamonte MJ, Stroup AM, Hunt SC. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007 Aug 23;357(8):753-61. doi: 10.1056/NEJMoa066603.
PMID: 17715409BACKGROUNDSjostrom L, Narbro K, Sjostrom CD, Karason K, Larsson B, Wedel H, Lystig T, Sullivan M, Bouchard C, Carlsson B, Bengtsson C, Dahlgren S, Gummesson A, Jacobson P, Karlsson J, Lindroos AK, Lonroth H, Naslund I, Olbers T, Stenlof K, Torgerson J, Agren G, Carlsson LM; Swedish Obese Subjects Study. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007 Aug 23;357(8):741-52. doi: 10.1056/NEJMoa066254.
PMID: 17715408BACKGROUNDCremieux PY, Buchwald H, Shikora SA, Ghosh A, Yang HE, Buessing M. A study on the economic impact of bariatric surgery. Am J Manag Care. 2008 Sep;14(9):589-96.
PMID: 18778174BACKGROUNDSantry HP, Gillen DL, Lauderdale DS. Trends in bariatric surgical procedures. JAMA. 2005 Oct 19;294(15):1909-17. doi: 10.1001/jama.294.15.1909.
PMID: 16234497BACKGROUNDFlum DR, Khan TV, Dellinger EP. Toward the rational and equitable use of bariatric surgery. JAMA. 2007 Sep 26;298(12):1442-4. doi: 10.1001/jama.298.12.1442. No abstract available.
PMID: 17895461BACKGROUNDMeguid MM, Glade MJ, Middleton FA. Weight regain after Roux-en-Y: a significant 20% complication related to PYY. Nutrition. 2008 Sep;24(9):832-42. doi: 10.1016/j.nut.2008.06.027.
PMID: 18725080BACKGROUNDNguyen NT. Reoperations and revisions in bariatric surgery. Surg Endosc. 2007 Nov;21(11):1907-8. doi: 10.1007/s00464-007-9572-6. Epub 2007 Sep 8. No abstract available.
PMID: 17828427BACKGROUNDhttp://www.asbs.org/htm/Private/resolution.html. American Society of Metabolic and Bariatric Surgeons.
BACKGROUNDDavies DJ, Baxter JM, Baxter JN. Nutritional deficiencies after bariatric surgery. Obes Surg. 2007 Sep;17(9):1150-8. doi: 10.1007/s11695-007-9208-x.
PMID: 18074487BACKGROUNDBrolin RE, Leung M. Survey of vitamin and mineral supplementation after gastric bypass and biliopancreatic diversion for morbid obesity. Obes Surg. 1999 Apr;9(2):150-4. doi: 10.1381/096089299765553395.
PMID: 10340768BACKGROUNDScopinaro N, Gianetta E, Civalleri D, Bonalumi U, Bachi V. Bilio-pancreatic bypass for obesity: 1. An experimental study in dogs. Br J Surg. 1979 Sep;66(9):613-7. doi: 10.1002/bjs.1800660905.
PMID: 497644BACKGROUNDScopinaro N, Gianetta E, Civalleri D, Bonalumi U, Bachi V. Bilio-pancreatic bypass for obesity: II. Initial experience in man. Br J Surg. 1979 Sep;66(9):618-20. doi: 10.1002/bjs.1800660906.
PMID: 497645BACKGROUNDScopinaro N, Papadia F, Marinari G, et al. (2007). Biliopancreatic diversion. In Surgical Management of Obesity (pp.239-51). Philadelphia: Saunders.
BACKGROUNDScopinaro N, Marinari G, Camerini G, Papadia F; 2004 ABS Consensus Conference. Biliopancreatic diversion for obesity: state of the art. Surg Obes Relat Dis. 2005 May-Jun;1(3):317-28. doi: 10.1016/j.soard.2005.03.216. No abstract available.
PMID: 16925242BACKGROUNDScopinaro N, Marinari GM, Pretolesi F, Papadia F, Murelli F, Marini P, Adami GF. Energy and nitrogen absorption after biliopancreatic diversion. Obes Surg. 2000 Oct;10(5):436-41. doi: 10.1381/096089200321594309.
PMID: 11054248BACKGROUNDGianetta E, Friedman D, Adami GF, Vitale B, Traverso E, Castagnola M, Semino G, Scopinaro N. Etiological factors of protein malnutrition after biliopancreatic diversion. Gastroenterol Clin North Am. 1987 Sep;16(3):503-4.
PMID: 3125106BACKGROUNDRen CJ. (2004). Laparoscopic malabsorption procedures: Complications. In Laparoscopic Bariatric Surgery (pp. 343-53). Philadelphia: Lippincott Williams & Wilkins.
BACKGROUNDScopinaro N, Gianetta E, Friedman D, Adami GF, Traverso E, Vitale B, Castagnola M, Semino G, Summa M, Bachi V. Surgical revision of biliopancreatic diversion. Gastroenterol Clin North Am. 1987 Sep;16(3):529-31.
PMID: 3436660BACKGROUNDScopinaro N. Biliopancreatic diversion: mechanisms of action and long-term results. Obes Surg. 2006 Jun;16(6):683-9. doi: 10.1381/096089206777346637. No abstract available.
PMID: 16756725BACKGROUNDScopinaro N. (2008). Biliopancreatic diversion: Revisional surgery. In obesity Surgery Principles and Practice (pp.277-83). New York: McGraw Hill.
BACKGROUNDAvinoah E, Ovnat A, Charuzi I. Nutritional status seven years after Roux-en-Y gastric bypass surgery. Surgery. 1992 Feb;111(2):137-42.
PMID: 1736382BACKGROUNDMoize V, Geliebter A, Gluck ME, Yahav E, Lorence M, Colarusso T, Drake V, Flancbaum L. Obese patients have inadequate protein intake related to protein intolerance up to 1 year following Roux-en-Y gastric bypass. Obes Surg. 2003 Feb;13(1):23-8. doi: 10.1381/096089203321136548.
PMID: 12630609BACKGROUNDPonsky TA, Brody F, Pucci E. Alterations in gastrointestinal physiology after Roux-en-Y gastric bypass. J Am Coll Surg. 2005 Jul;201(1):125-31. doi: 10.1016/j.jamcollsurg.2005.03.021. No abstract available.
PMID: 15978453BACKGROUNDFaintuch J, Matsuda M, Cruz ME, Silva MM, Teivelis MP, Garrido AB Jr, Gama-Rodrigues JJ. Severe protein-calorie malnutrition after bariatric procedures. Obes Surg. 2004 Feb;14(2):175-81. doi: 10.1381/096089204322857528.
PMID: 15018745BACKGROUNDWhite S, Brooks E, Jurikova L, Stubbs RS. Long-term outcomes after gastric bypass. Obes Surg. 2005 Feb;15(2):155-63. doi: 10.1381/0960892053268282.
PMID: 15802056BACKGROUNDFobi MA, Lee H, Igwe D Jr, Felahy B, James E, Stanczyk M, Tambi J, Eyong P. Revision of failed gastric bypass to distal Roux-en-Y gastric bypass: a review of 65 cases. Obes Surg. 2001 Apr;11(2):190-5. doi: 10.1381/096089201321577866.
PMID: 11355025BACKGROUNDSugerman HJ, Kellum JM, DeMaria EJ. Conversion of proximal to distal gastric bypass for failed gastric bypass for superobesity. J Gastrointest Surg. 1997 Nov-Dec;1(6):517-24; discussion 524-6. doi: 10.1016/s1091-255x(97)80067-4.
PMID: 9834387BACKGROUNDKushner R. Managing the obese patient after bariatric surgery: a case report of severe malnutrition and review of the literature. JPEN J Parenter Enteral Nutr. 2000 Mar-Apr;24(2):126-32. doi: 10.1177/0148607100024002126.
PMID: 10772194BACKGROUNDMazess RB, Barden HS, Drinka PJ, Bauwens SF, Orwoll ES, Bell NH. Influence of age and body weight on spine and femur bone mineral density in U.S. white men. J Bone Miner Res. 1990 Jun;5(6):645-52. doi: 10.1002/jbmr.5650050614.
PMID: 2382588BACKGROUNDLiel Y, Ulmer E, Shary J, Hollis BW, Bell NH. Low circulating vitamin D in obesity. Calcif Tissue Int. 1988 Oct;43(4):199-201. doi: 10.1007/BF02555135.
PMID: 3145124BACKGROUNDCoates PS, Fernstrom JD, Fernstrom MH, Schauer PR, Greenspan SL. Gastric bypass surgery for morbid obesity leads to an increase in bone turnover and a decrease in bone mass. J Clin Endocrinol Metab. 2004 Mar;89(3):1061-5. doi: 10.1210/jc.2003-031756.
PMID: 15001587BACKGROUNDParfitt AM, Podenphant J, Villanueva AR, Frame B. Metabolic bone disease with and without osteomalacia after intestinal bypass surgery: a bone histomorphometric study. Bone. 1985;6(4):211-20. doi: 10.1016/8756-3282(85)90003-1.
PMID: 3840379BACKGROUNDVan Loan MD, Johnson HL, Barbieri TF. Effect of weight loss on bone mineral content and bone mineral density in obese women. Am J Clin Nutr. 1998 Apr;67(4):734-8. doi: 10.1093/ajcn/67.4.734.
PMID: 9537621BACKGROUNDBuffington C, Walker B, Cowan GS Jr, Scruggs D. Vitamin D Deficiency in the Morbidly Obese. Obes Surg. 1993 Nov;3(4):421-424. doi: 10.1381/096089293765559142.
PMID: 10757956BACKGROUNDFlancbaum L, Belsley S, Drake V, Colarusso T, Tayler E. Preoperative nutritional status of patients undergoing Roux-en-Y gastric bypass for morbid obesity. J Gastrointest Surg. 2006 Jul-Aug;10(7):1033-7. doi: 10.1016/j.gassur.2006.03.004.
PMID: 16843874BACKGROUNDHamoui N, Anthone G, Crookes PF. Calcium metabolism in the morbidly obese. Obes Surg. 2004 Jan;14(1):9-12. doi: 10.1381/096089204772787211.
PMID: 14980026BACKGROUNDYbarra J, Sanchez-Hernandez J, Gich I, De Leiva A, Rius X, Rodriguez-Espinosa J, Perez A. Unchanged hypovitaminosis D and secondary hyperparathyroidism in morbid obesity after bariatric surgery. Obes Surg. 2005 Mar;15(3):330-5. doi: 10.1381/0960892053576758.
PMID: 15826464BACKGROUNDChapin BL, LeMar HJ Jr, Knodel DH, Carter PL. Secondary hyperparathyroidism following biliopancreatic diversion. Arch Surg. 1996 Oct;131(10):1048-52; discussion 1053. doi: 10.1001/archsurg.1996.01430220042009.
PMID: 8857901BACKGROUNDBell NH, Greene A, Epstein S, Oexmann MJ, Shaw S, Shary J. Evidence for alteration of the vitamin D-endocrine system in blacks. J Clin Invest. 1985 Aug;76(2):470-3. doi: 10.1172/JCI111995.
PMID: 3839801BACKGROUNDCompston JE, Vedi S, Ledger JE, Webb A, Gazet JC, Pilkington TR. Vitamin D status and bone histomorphometry in gross obesity. Am J Clin Nutr. 1981 Nov;34(11):2359-63. doi: 10.1093/ajcn/34.11.2359.
PMID: 7304477BACKGROUNDHey H, Stokholm KH, Lund B, Lund B, Sorensen OH. Vitamin D deficiency in obese patients and changes in circulating vitamin D metabolites following jejunoileal bypass. Int J Obes. 1982;6(5):473-9.
PMID: 6983505BACKGROUNDRiedt CS, Brolin RE, Sherrell RM, Field MP, Shapses SA. True fractional calcium absorption is decreased after Roux-en-Y gastric bypass surgery. Obesity (Silver Spring). 2006 Nov;14(11):1940-8. doi: 10.1038/oby.2006.226.
PMID: 17135609BACKGROUNDJohnson JM, Maher JW, DeMaria EJ, Downs RW, Wolfe LG, Kellum JM. The long-term effects of gastric bypass on vitamin D metabolism. Ann Surg. 2006 May;243(5):701-4; discussion 704-5. doi: 10.1097/01.sla.0000216773.47825.c1.
PMID: 16633006BACKGROUNDAllied Health Sciences Section Ad Hoc Nutrition Committee; Aills L, Blankenship J, Buffington C, Furtado M, Parrott J. ASMBS Allied Health Nutritional Guidelines for the Surgical Weight Loss Patient. Surg Obes Relat Dis. 2008 Sep-Oct;4(5 Suppl):S73-108. doi: 10.1016/j.soard.2008.03.002. Epub 2008 May 19. No abstract available.
PMID: 18490202BACKGROUNDBrolin RE, Gorman RC, Milgrim LM, Kenler HA. Multivitamin prophylaxis in prevention of post-gastric bypass vitamin and mineral deficiencies. Int J Obes. 1991 Oct;15(10):661-7.
PMID: 1752727BACKGROUNDGoode LR, Brolin RE, Chowdhury HA, Shapses SA. Bone and gastric bypass surgery: effects of dietary calcium and vitamin D. Obes Res. 2004 Jan;12(1):40-7. doi: 10.1038/oby.2004.7.
PMID: 14742841BACKGROUNDJohnson JM, Maher JW, Samuel I, Heitshusen D, Doherty C, Downs RW. Effects of gastric bypass procedures on bone mineral density, calcium, parathyroid hormone, and vitamin D. J Gastrointest Surg. 2005 Nov;9(8):1106-10; discussion 1110-1. doi: 10.1016/j.gassur.2005.07.012.
PMID: 16269381BACKGROUNDYoussef Y, Richards WO, Sekhar N, Kaiser J, Spagnoli A, Abumrad N, Torquati A. Risk of secondary hyperparathyroidism after laparoscopic gastric bypass surgery in obese women. Surg Endosc. 2007 Aug;21(8):1393-6. doi: 10.1007/s00464-007-9228-6. Epub 2007 Feb 21.
PMID: 17318692BACKGROUNDMarceau P, Biron S, Lebel S, Marceau S, Hould FS, Simard S, Dumont M, Fitzpatrick LA. Does bone change after biliopancreatic diversion? J Gastrointest Surg. 2002 Sep-Oct;6(5):690-8. doi: 10.1016/s1091-255x(01)00086-5.
PMID: 12399058BACKGROUNDHamoui N, Kim K, Anthone G, Crookes PF. The significance of elevated levels of parathyroid hormone in patients with morbid obesity before and after bariatric surgery. Arch Surg. 2003 Aug;138(8):891-7. doi: 10.1001/archsurg.138.8.891.
PMID: 12912749BACKGROUNDNewbury L, Dolan K, Hatzifotis M, Low N, Fielding G. Calcium and vitamin D depletion and elevated parathyroid hormone following biliopancreatic diversion. Obes Surg. 2003 Dec;13(6):893-5. doi: 10.1381/096089203322618722.
PMID: 14738677BACKGROUNDSlater GH, Ren CJ, Siegel N, Williams T, Barr D, Wolfe B, Dolan K, Fielding GA. Serum fat-soluble vitamin deficiency and abnormal calcium metabolism after malabsorptive bariatric surgery. J Gastrointest Surg. 2004 Jan;8(1):48-55; discussion 54-5. doi: 10.1016/j.gassur.2003.09.020.
PMID: 14746835BACKGROUNDDolan K, Hatzifotis M, Newbury L, Fielding G. A comparison of laparoscopic adjustable gastric banding and biliopancreatic diversion in superobesity. Obes Surg. 2004 Feb;14(2):165-9. doi: 10.1381/096089204322857500.
PMID: 15018743BACKGROUNDDeMaria EJ. Is gastric bypass superior for the surgical treatment of obesity compared with malabsorptive procedures? J Gastrointest Surg. 2004 May-Jun;8(4):401-3. doi: 10.1016/j.gassur.2003.12.022. No abstract available.
PMID: 15120361BACKGROUNDDolan K, Hatzifotis M, Newbury L, Lowe N, Fielding G. A clinical and nutritional comparison of biliopancreatic diversion with and without duodenal switch. Ann Surg. 2004 Jul;240(1):51-6. doi: 10.1097/01.sla.0000129280.68540.76.
PMID: 15213618BACKGROUNDBrolin RE, Gorman JH, Gorman RC, Petschenik AJ, Bradley LB, Kenler HA, Cody RP. Prophylactic iron supplementation after Roux-en-Y gastric bypass: a prospective, double-blind, randomized study. Arch Surg. 1998 Jul;133(7):740-4. doi: 10.1001/archsurg.133.7.740.
PMID: 9688002BACKGROUNDBrolin RE, LaMarca LB, Kenler HA, Cody RP. Malabsorptive gastric bypass in patients with superobesity. J Gastrointest Surg. 2002 Mar-Apr;6(2):195-203; discussion 204-5. doi: 10.1016/s1091-255x(01)00022-1.
PMID: 11992805BACKGROUNDMarceau P, Hould FS, Lebel S, Marceau S, Biron S. Malabsorptive obesity surgery. Surg Clin North Am. 2001 Oct;81(5):1113-27. doi: 10.1016/s0039-6109(05)70187-0.
PMID: 11589248BACKGROUNDBrolin RE, Gorman JH, Gorman RC, Petschenik AJ, Bradley LJ, Kenler HA, Cody RP. Are vitamin B12 and folate deficiency clinically important after roux-en-Y gastric bypass? J Gastrointest Surg. 1998 Sep-Oct;2(5):436-42. doi: 10.1016/s1091-255x(98)80034-6.
PMID: 9843603BACKGROUNDHalverson JD. Micronutrient deficiencies after gastric bypass for morbid obesity. Am Surg. 1986 Nov;52(11):594-8.
PMID: 3777703BACKGROUNDMarcuard SP, Sinar DR, Swanson MS, Silverman JF, Levine JS. Absence of luminal intrinsic factor after gastric bypass surgery for morbid obesity. Dig Dis Sci. 1989 Aug;34(8):1238-42. doi: 10.1007/BF01537272.
PMID: 2666054BACKGROUNDSkroubis G, Sakellaropoulos G, Pouggouras K, Mead N, Nikiforidis G, Kalfarentzos F. Comparison of nutritional deficiencies after Roux-en-Y gastric bypass and after biliopancreatic diversion with Roux-en-Y gastric bypass. Obes Surg. 2002 Aug;12(4):551-8. doi: 10.1381/096089202762252334.
PMID: 12194550BACKGROUNDRhode BM, Tamin H, Gilfix BM, Sampalis JS, Nohr C, MacLean LD. Treatment of Vitamin B12 Deficiency after Gastric Surgery for Severe Obesity. Obes Surg. 1995 May;5(2):154-158. doi: 10.1381/096089295765557953.
PMID: 10733805BACKGROUNDOcon Breton J, Perez Naranjo S, Gimeno Laborda S, Benito Ruesca P, Garcia Hernandez R. [Effectiveness and complications of bariatric surgery in the treatment of morbid obesity]. Nutr Hosp. 2005 Nov-Dec;20(6):409-14. Spanish.
PMID: 16335025BACKGROUNDBoylan LM, Sugerman HJ, Driskell JA. Vitamin E, vitamin B-6, vitamin B-12, and folate status of gastric bypass surgery patients. J Am Diet Assoc. 1988 May;88(5):579-85.
PMID: 3367015BACKGROUNDMechanick JI, Kushner RF, Sugerman HJ, Gonzalez-Campoy JM, Collazo-Clavell ML, Guven S, Spitz AF, Apovian CM, Livingston EH, Brolin R, Sarwer DB, Anderson WA, Dixon J. American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery Medical Guidelines for Clinical Practice for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient. Surg Obes Relat Dis. 2008 Sep-Oct;4(5 Suppl):S109-84. doi: 10.1016/j.soard.2008.08.009. Epub 2008 Aug 19.
PMID: 18848315BACKGROUND
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Francisco M Tercero, MD
Research Associate, University of California San Francisco
- PRINCIPAL INVESTIGATOR
Kelvin D Higa, MD
Professor of Surgery, University of California San Francisco
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
December 26, 2009
First Posted
December 31, 2009
Study Start
March 1, 2009
Primary Completion
August 1, 2009
Study Completion
October 1, 2009
Last Updated
January 1, 2010
Record last verified: 2009-12